Browsing by Author Karabina, S. A. P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 17 of 17
TitleAuthor(s)Issue date
Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemiaTsimihodimos, V.; Karabina, S. A. P.; Tambaki, A. P.; Bairaktari, E.; Miltiadous, G.; Goudevenos, J. A.; Cariolou, M. A.; Chapman, M. J.; Tselepis, A. D.; Elisaf, M.24-Nov-2015
Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activityTselepis, A. D.; Elisaf, M.; Besis, S.; Karabina, S. A. P.; Chapman, M. J.; Siamopoulou, A.24-Nov-2015
Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIBTsimihodimos, V.; Karabina, S. A. P.; Tambaki, A. P.; Bairaktari, E.; Goudevenos, J. A.; Chapman, M. J.; Elisaf, M.; Tselepis, A. D.24-Nov-2015
Distribution of Paf-Acetylhydrolase Activity in Human Plasma Low-Density-Lipoprotein SubfractionsKarabina, S. A. P.; Liapikos, T. A.; Grekas, G.; Goudevenos, J.; Tselepis, A. D.24-Nov-2015
Glibenclamide improves postprandial hypertriglyceridaemia in Type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levelsSkrapari, I.; Perrea, D.; Ioannidis, I.; Karabina, S. A. P.; Elisaf, M.; Tselepis, A. D.; Karagiannacos, P.; Katsilambros, N.24-Nov-2015
High density lipoprotein changes in patients with microvascular anginaElisaf, M. S.; Karabina, S. A. P.; Tselepis, A. D.24-Nov-2015
Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemiaKarabina, S. A. P.; Elisaf, M.; Bairaktari, E.; Tzallas, C.; Siamopoulos, K. C.; Tselepis, A. D.24-Nov-2015
Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemiaElisaf, M.; Karabina, S. A. P.; Bairaktari, E.; Goudevenos, J. A.; Siamopoulos, K. C.; Tselepis, A. D.24-Nov-2015
The inflammatory state in active juvenile rheumatoid arthritis is associated with hypo HDL-EMIA and reduced lipoprotein-associated PAF-acetylhydrolase activityTselepis, A. D.; Elisaf, M. S.; Besis, S.; Karabina, S. A. P.; Chapman, M. J.; Siamopoulou, A.24-Nov-2015
N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDLTselepis, A. D.; Karabina, S. A. P.; Stengel, D.; Piedagnel, R.; Chapman, M. J.; Ninio, E.24-Nov-2015
PAF-acetylhydrolase activity in familial hypercholesterolaemiaTselepis, A. D.; Karabina, S. A. P.; Elisaf, M.24-Nov-2015
PAF-acetylhydrolase activity on Lp(a) before and during Cu2+-induced oxidative modification in vitroKarabina, S. A. P.; Elisaf, M. C.; Goudevenos, J.; Siamopoulos, K. C.; Sideris, D.; Tselepis, A. D.24-Nov-2015
Paf-Degrading Acetylhydrolase Is Preferentially Associated with Dense Ldl and Vhdl-1 in Human Plasma - Catalytic Characteristics and Relation to the Monocyte-Derived EnzymeTselepis, A. D.; Dentan, C.; Karabina, S. A. P.; Chapman, M. J.; Ninio, E.24-Nov-2015
Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis proceduresMilionis, H. J.; Elisaf, M. S.; Karabina, S. A. P.; Bairaktari, E.; Tselepis, A. D.; Siamopoulos, K. C.24-Nov-2015
Platelet-Activating-Factor Formation during Oxidative Modification of Low-Density-Lipoprotein When Paf-Acetylhydrolase Has Been InactivatedLiapikos, T. A.; Antonopoulou, S.; Karabina, S. A. P.; Tsoukatos, D. C.; Demopoulos, C. A.; Tselepis, A. D.24-Nov-2015
Reduced HDL levels are a major feature of the dyslipidemia characteristic of juvenile chronic arthritisTselepis, A. D.; Besis, S.; Elisaf, M.; Karabina, S. A. P.; Lapatsanis, P. D.; Chapman, M. J.; Siamopoulou, A.24-Nov-2015
Repaglinide reduces postprandial chylomicron-deficient plasma triglycerides in patients with type 2 diabetesTentolouris, N.; Kolia, M.; Tselepis, A. D.; Perea, D.; Kitsou, E.; Alevizou, V.; Tambaki, A. P.; Karabina, S. A. P.; Sala, C.; Fragoulopoulos, V.; Katsilambros, N.24-Nov-2015